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Abstract.  Some biologically active organotellurium 
compounds exhibit inhibitory potency against Ca-
thepsin B.  In this study, an alkyl derivative, viz. 
[CH3(CH2)2C(I)=C(H)](nBu)TeI2, 1, has been struc-
turally characterised by X-ray crystallography and 
shown to be coordinated within a C2I2 donor set.  
When the stereochemically active lone pair of elec-
trons is taken into account, a distorted trigonal bi-
pyramidal geometry results with the iodide atoms in 
axial positions.  Both intra- and inter-molecular 
Te…I interactions are also noted.  If all interactions 
are considered, the coordination geometry is based 
on a Ψ-pentagonal bipyramidal geometry.  An unu-
sual feature of the structure is the curving of the 
functionalised C5 chain.  This feature has been ex-
plored by DFT methods and shown to arise as a 
result of close C–H…I interactions.  A docking study 
(Cathepsin B) was performed to understand the 
inhibition mechanism and to compare the new re-
sults with previous observations.  Notably, 1 has the 
same pose exhibited by analogous biologically ac-
tive compounds with aryl groups.  Thus, the present 
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study suggests that (alkyl)2TeX2 compounds should 
also be evaluated for biological activity. 
 
*
 Correspondence authors: ignez@df.ufscar.br (I.C.); ed-
wardt@sunway.edu.my (E.R.T.T.) 
 
Introduction 
The lysosomal cysteine protease, Cathepsin B, hereafter 
Cat B, is responsible for the degradation and processing of 
proteins in living organisms [1, 2].  The structure is char-
acterised by a thiol in the cysteine residue, Cys29, and a 
histidine, His199, in the catalytic site [3, 4], and therefore, 
in the context of metal-based drugs, offers the opportunity 
for coordination to metal centres.  Herein, the interaction 
of an organotellurium(IV) compound, diiodo(2-iodopent-
1-en-1-yl)butyl-λ4-tellane (1), Fig. 1, with Cat B is inves-
tigated employing docking studies. 
 
 
Fig. 1.  Chemical diagrams of diiodo(2-iodopent-1-en-1-yl)butyl-
λ4-tellane, (1), ammonium trichloro (dioxoethylene-O,Oꞌ)tellurate 
(2), and dichloro-(2-chloro-phenylvinyl)-4-methoxyphenyl-
tellurium(IV) (3). 
The important role of Cat B is indicated in a variety of 
human disease.  Amongst these is tumour metastasis [5], as 
the metastatic potential of cancer cells is moderated by Cat 
B [6].  Along with other proteases, Cat B is considered both 
as a biomarker and a therapeutic target, especially in malig-
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nant melanoma [7]. Neurodegenerative disorders are also 
thought to involve a role for Cat B [8].  In patients afflicted 
with rheumatoid arthritis, a disorder associated with the 
degradation of the extracellular matrix components [9], Cat 
B has been reported to be up-regulated [10].  Thus, Cat B 
presents an important target in developing therapies in 
cancer, arthritis and other disease.  This being the case, the 
generation of selective inhibitors of Cat B is a definite op-
tion in drug development.  Good inhibitors, as discussed 
below, have been shown to typically bind amino acids in 
the S1ꞌ and S2ꞌ sub-sites [2]. 
In this context, the tellurium atom in a number of or-
ganotellurium compounds has been shown to bind sulphur 
at the Cys29 site thereby rendering the protein inactive [9-
12].  The most promising tellurium-based therapeutic agent, 
ammonium trichloro (dioxoethylene-O,Oꞌ)tellurate 
(AS101), 2 in Fig. 1, was the first tellurium compound 
shown to inhibit non-lysosomal Cat B [11, 13].  In develop-
ing new therapeutic organotellurium(IV) compounds, 
Cunha et al. showed organotelluranes to be irreversible 
inhibitors of cysteine cathepsins [12].  Further, strategic 
modification of substituents can be exploited to alter speci-
ficity for different cathepsins, e.g. Cat B, L, S and K, and to 
relate inhibition efficiency to sub-site specificity [12].  In 
the present study, a docking study of those compounds, i.e. 
dichloro-(2-chloro-phenylvinyl)-4-methoxyphenyl-
tellurium(IV) (3 in Fig. 1), was performed to understand the 
inhibition mechanism [14]. 
As a continuation of on-going interest in tellurium com-
pounds and their activity in biological environments, the 
present docking study of a mixed alkyl/alkenyl derivative, 
1, was undertaken.  The study was motivated in order to 
determine whether inhibition of Cat B by related com-
pounds required the present of an aryl group(s).  The pre-
sent report details the crystal structure determination of 1, 
its geometry optimised structure as well as docking studies 
in Cat B. 
Experimental 
Synthesis and crystal growth 
Compound 1 was synthesised and characterised as per the 
literature procedure [15].  Crystals for the X-ray structure 
determination were obtained by slow evaporation of its 
chloroform/petroleum ether (1/1 v/v) solution. 
 
Crystal structure determination 
Intensity data for 1 were measured at 98 K on a Rigaku 
AFC12κ/SATURN724 diffractometer fitted with MoKα 
radiation (λ = 0.71073 Å).  Data processing and absorption 
corrections were accomplished with CrystalClear [16] and 
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ABSCOR [17], respectively.  Unit cell data, X-ray data 
collection parameters, and details of the structure refine-
ment are given in Table 1.  The structure was solved by 
direct methods [18] and full-matrix least-squares [19] re-
finement on F2 (anisotropic displacement parameters and 
C-bound H atoms in their idealised positions).  A weighting 
scheme of the form w = 1/[σ2(Fo2) + (0.055P)2 + 2.057P] 
where P = (Fo2 + 2Fc2)/3 was introduced.  The maximum 
and minimum residual electron density peaks of 1.47 and 
2.26 eÅ-3, respectively, were located 0.91 and 0.77 Å from 
the Te atom.  Two reflections, i.e. (3 1 2) and (5 9 2), were 
omitted from the final cycles of refinement owing to poor 
agreement.  The programs WinGX [20], PLATON [21], 
ORTEP-3 for Windows [20], Qmol [22] and DIAMOND 
[23] were also used in the study. 
 
Table 1. Crystallographic data and refinement details for 1.1 
Formula C9H17I3Te 
Formula weight 633.53 
Crystal colour, habit Colourless prism 
Crystal size/mm 0.10 x 0.20 x 0.20 
Crystal system triclinic 
Space group P¯1 
a/Å 6.599(3) 
b/Å 10.917(5) 
c/Å 11.451(6) 
α/° 86.54(3) 
β/° 83.28(3) 
γ/° 81.13(3) 
V/Å3 808.7(7) 
Z/Z′ 2/1 
Dc/g cm-3 2.602 
F(000) 564 
µ(MoKα)/mm-1 7.534 
Measured data 8639 
θ range/° 1.8 – 29.8 
Unique data 4040 
Observed data (I ≥ 
2.0σ(I)) 
3888 
R, obs. data; all data 0.038; 0.040 
Rw, obs. data; all data 0.102; 0.104 
∆ρmax, min/e Å–3 1.47; 2.26 
1
 Supplementary Material: Crystallographic data (excluding struc-
ture factors) for the structures reported in this paper have been 
deposited with the Cambridge Crystallographic Data Centre as 
supplementary publication no. CCDC-1451922. Copies of availa-
ble material can be obtained free of charge, on application to 
CCDC, 12 Union Road, Cambridge CB2 1EZ, UK, (fax: +44-
(0)1223-336033 or e-mail: deposit@ccdc.cam.ac.uk). The list of 
Fo/Fc-data is available from the author up to one year after the 
publication has appeared. 
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Computational chemistry 
The calculations were performed using the computational 
package Firefly [24, 25].  The structures were optimised at 
the B3LYP/LANL2Zdp level [26-31] with an algorithm 
based in Quadratic Approximation (QA) [32] and 10-5 a.u. 
for the threshold gradient value.  The inner electrons for 
tellurium and iodide were treated with the Effective Core 
Potential (ECP) approximation [26-31].  The NBO donor-
acceptor pairs were checked.  The interaction energies were 
calculated according to second-order stabilisation (E2PRT) 
and steric exchange energies of NBO analyses [33].  Struc-
tures, charts and surfaces, were drawn using the wxMac-
MolPlt and JMol softwares [34, 35]. 
 
Docking studies 
The GOLD program (version 4.1.1) [36] was used to per-
form the docking calculation of “ligand” 1 using a genetic 
algorithm to explore the full range of ligand conformational 
flexibility and partial flexibility of the protein binding site.  
Each conformational result of the ligand has a score 
(GOLDScore) given by the following sum: 
 
f = Shb_ext + Svdw_ext + Shb_int + Svdw_int 
 
where Shb_ext is the protein-ligand hydrogen bonding 
score, and Shb_int the internal hydrogen bonding of the 
ligand. 
The coordinates for the investigated protein, Cat B, 
were obtained from the PDB and PDBsum sites [37].  Be-
fore the calculations, the hydrogen atoms were attached to 
the protein and all water molecules and the non-protein-
atoms removed.  On the basis of previous studies [5, 6, 12], 
which indicate the tellurium atom of related organotelluri-
um(IV) compounds binds the protein at the S-Cys29 site, 
the docking calculations were conducted with a sphere of 
12 Å about the active site with both S-Cys29 and His199 
in their ionised forms, i.e. the thiol is pre-activated by trans-
ferring its proton to the ring-imine-nitrogen atom leading to 
the thiolate/ imidazolium tautomer.  To inhibit the protein, 
the tellurium atom must bind to the S-Cys29 [13, 38] indi-
cating that one iodide atom must be a leaving group.  
Therefore, the following calculations were performed: i) 
analysis was made with the complete molecule of 1 with 
the protein, and ii) since the tellurium-bound iodide atoms 
are not equivalent, calculations were performed to ascertain 
which of these was the better leaving group, i.e. yielding 1ꞌ 
which corresponds to 1 less one tellurium-bound iodide, i.e. 
{[CH3(CH2)2C(I)=C(H)](nBu)TeI}+.  The docking results 
were plotted using D.S. Visualizer v3.5 [39]. 
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Results 
Experimental molecular structure 
The molecular structure of 1, as determined by X-ray crys-
tallography, is shown in Fig. 2 and selected geometric pa-
rameters are collated in Table 2.  The immediate coordina-
tion geometry of the tellurium atom is defined by two io-
dide atoms and two carbon atoms.  These donor atoms 
along with a stereochemically active lone pair of electrons 
define a distorted trigonal bipyramidal geometry with the 
iodide atoms being mutually trans defining an axial angle of 
176.196(13)º.  The tellurium atom also forms a weak intra-
molecular interaction with the I3 atom of the vinyl group, 
3.5455(19) Å, as well as intermolecularly by I2i, 3.845(2) 
Å; symmetry operation i: -x, 1-y, 1-z.  The participation of 
the I2 atom in the secondary interaction explains the elon-
gation of the Te–I2 bond length, i.e. 2.9334(13) Å, with 
respect to the Te–I1 bond length of 2.9083(13) Å.  Both of 
the Te…I secondary interactions are less than the sum of the 
van der Waals radii of Te and I, i.e. 4.04 Å [40].  In consid-
eration of the additional Te…I interactions that occur ap-
proximately normal to the axially-bound iodide atoms, the 
coordination geometry may be described as distorted ψ- 
pentagonal bipyramidal. 
 
Fig. 2.  Molecular structure of 1 showing atom labelling and 
displacement ellipsoids at the 50% probability level. 
Table 2.  Summary of key geometric parameters (Å, º) for 1.1 
Parameter 
 
Parameter  
Te‒C1 2.101(5) Te‒C6 2.169(5) 
Te‒I1 2.9083(13) Te‒I2 2.9334(13) 
Te…I3 3.5455(19) Te…I2i 3.845(2) 
C2‒I3 2.114(5) C1=C2 1.328(7) 
I1‒Te‒I2 176.196(13) I1‒Te‒C1 88.50(14) 
I1‒Te‒C6 92.05(14) I2‒Te‒C1 87.77(14) 
I2‒Te‒C6 87.37(14) C1‒Te‒C6 92.74(19) 
Te‒C1‒C2 124.3(4) Te‒C6‒C7 112.6(3) 
C1‒C2‒C3 124.4(5) C1‒C2‒I3 119.2(4) 
C3‒C2‒I3 116.4(3)   
 
1
 Symmetry operation i: -x, 1-y, 1-z. 
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The configuration about the vinyl C1=C2 bond is Z.  An 
unexpected feature of the structure is the conformation of 
the C5 chain.  Whereas the n-butyl group exhibits an open, 
all-trans conformation with the C6‒C7‒C8‒C9 torsion 
angle being 178.6(5)º, a pronounced kink is observed in the 
C5 chain as seen in the values of the C1‒C2‒C3‒C4 and 
C2‒C3‒C4‒C5 torsion angles of -118.1(6) and 57.5(7)º, 
respectively. 
There are three literature precedents for 1, i.e. with the 
general formula [RC(Xꞌ)=C(H)](nBu)TeX2.  These, i.e. X = 
Xꞌ = Cl and R = Ph [41], X = Xꞌ = Br and R = CH2OH [42] 
and X = Cl, Xꞌ = Br and R = Cy [43], each feature a Z con-
figuration about the vinyl bond and an intramolecular Te…X 
interaction. 
In the molecular packing, centrosymmetric aggregates 
are formed via the intermolecular Te…I2i interactions men-
tioned above, Fig. 3a.  These are connected via vinyl-C1–
H…I1ii [C1–H1…I1ii = 3.04 Å, C1…I1ii = 3.962(5) Å, with 
angle at H1 = 163º for ii: -x, 1-y -z] interactions into a su-
pramolecular chain along the c-axis.  Type II halogen bond-
ing interactions [44] between I2 and I3iii atoms [3.829(2) Å 
cf. sum of their van der Waals radii of 3.96 Å [40]; sym-
metry operation iii: -1+x, y, z] link the chains into a supra-
molecular layer in the ac-plane, Fig. 3b, and these layers 
stack along the b-axis being separated by hydrophobic 
interactions, Fig. 3c. 
 
 
(a) 
 
(b) 
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(c) 
Fig. 3.  Crystal packing in 1: (a) centrosymmetric aggregate medi-
ated by Te…I1 interactions.  The intramolecular Te…I3 interactions 
are also indicated to emphasise the distorted ψ-pentagonal bi-
pyramidal geometry, (b) view in projection down the b-axis of the 
unit cell showing the supramolecular layer sustained by C–H…I 
and I…I interactions, and (c) view of the unit cell contents down 
the a-axis highlighting the stacking of layers along the b-axis.  
One supramolecular layer is highlighted in space-filling mode.  
The Te…I, C–H…I and I…I interactions are represented as black, 
blue and pink dashed lines, respectively. 
 
Theoretical molecular structures 
The unrestrained optimization of the structure of 1 gave rise 
to two conformations with very similar minimum-energy 
(see below).  In one conformation the n-propyl substituent 
at the C=C double bond is bent, hereafter named as the 
closed conformer. In the second, open conformer, the ali-
phatic substituent is straight, see Fig. 4. 
 
(a) 
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(b) 
Fig. 4.  Optimised structures of the organotellurium studied 
herein: (a) closed conformer and (b) open conformer.  The 
C–H…I interactions are shown as red dashed lines. 
 
Both conformations have essentially the same energy, 
i.e. they are equally stable, Table 3, with the open conform-
er being marginally more stable.  Initially, it was anticipat-
ed that the closed conformation would be less stable due to 
the higher steric hindrance imposed by bent n-propyl sub-
stituent (Table 4).  According to the data in Table 5, the 
difference between steric effects is actually small and might 
be compensated by weak intramolecular C–H...I hydrogen 
bonds, Fig. 5 and Table 5.  The NBO analysis indicates 
hyperconjugation between the I3 and methylene-H atoms.  
Even though the distance between donor-acceptor atoms of 
the methyl-H…I interaction (C…I = 4.92 Å and H…I = 3.85 
Å) are 15% greater than the sum of their van der Waals 
radii [40, 45], the C5–H5…I2 interactions are identified by 
the NBO analysis as weak hyperconjugation between the 
lone pair of the iodide and anti-bonding orbitals of the 
C(methyl)-H bond (nI → σ*C-H), Fig. 5c, having a second-
order stabilisation energy of ca.  0.1 kcal.mol-1.  It should 
be noted that the crystallographic structure has a confor-
mation close to that of the closed conformer with a r.m.s. 
deviation for their superposition of 0.06 Å, Fig. 6. 
 
 
 
 
Table 3. Relative energies (kcal.mol-1) of the energy-minimised 
conformers of 1. 
Conformation ∆Gө (298.15 K) ∆EZPE ∆E 
open 0.0 0.0 0.0 
closed 0.7 0.5 0.3 
 
Table 4. Relative steric interactions of the n-propyl substituents 
(kcal.mol-1) 
Conformation Steric exchange energy  
open 0.0 
closed  0.2 
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Table 5. NBO analysis of the C–H...I interactions.  
Conformation Interaction E2PRT/kcal.mol-1 
open nI2 → σ*C5-H5a – 
nI3 → σ*C4-H4a -0.3 
closed nI2 → σ*C5-H5a -0.1 
nI3 → σ*C4-H4a -0.3 
 
 
(a) 
 
(b) 
 
(c) 
Fig. 5.  Hyperconjugative nI → σ*C-H interactions: (a) nI3 → σ*C4-
H4 in open conformer; (b) nI3 → σ*C4-H4 in closed conformer; (c) 
nI2 → σ*C5-H5 in closed conformer.  Isovalue= 0.02 au; nI = blue 
and red lobes; σ*C-H = green and yellow lobes. 
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Fig. 6.  Overlay of the experimental (black) and geometry opti-
mised closed structure (red) of 1.  Molecules have been superim-
posed so that the central TeI2 moieties are coincident, and hydro-
gen atoms have been removed. 
 
Docking resultsDocking experiments were conducted 
with 1 and 1ꞌ, i.e. compound 1 less one iodide (see Section 
Docking studies).  The calculations showed that the better 
leaving atom was I1, giving rise to a GOLDScore of 43.3 
cf. 41.3 for I2.  Once the I1 atom was removed, a Te–SG 
bond could be formed, i.e. with the sulphur atom of the 
Cys29 residue, at an optimised distance of 2.91 Å.  This 
compares well with the results of a search of the Cambridge 
Structural Data Base [46] gave a range for the Te–S bond 
lengths of 2.38-3.70 Å (average 2.73 Å for 1873 observa-
tions).  Moreover, the same value was found in the crystal 
structure of the sarcosine oxidase complex with a tellurium 
compound [47] and in related docking studies [14, 38]. 
Given that two distinct conformations were found for 1, 
with only a small energy difference indicated from the 
computational study (see above), both were evaluated in the 
docking study.  It is interesting to note that, regardless of 
the initial conformation, the final conformation in the active 
site was the closed form, hereafter Closed 1ꞌ.  An image 
showing the interaction of 1ꞌ with the active site of Cat B is 
shown in Fig. 7.  In addition to the formation of the Te–S 
bond, Te…O(Gly27) and Te…H(Gly73) interactions are 
noted; Table 6 collates a summary of all the nearest con-
tacts in the active site.  In previous work, similar interac-
tions between the tellurium “ligand” and the active site of 
Cat B were seen (see below) [14, 38]. 
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Fig. 7.  The coordination around the Te atom and the C-
H…I(vinyl) interactions for 1ꞌ bound to the active site of Cat B. 
 
Table 6.  Main interactions between Cathepsin B residues and selected 
pose of the closed 1ꞌ ligand. 
Closed 1ꞌ-GOLDScore: 43.3 kcal/mol 
 
Sub-site Closed 1ꞌ-Cat B interaction 
distance 
(Å) 
Closed 1ꞌ 
atom 
1gmy 
atom1 
S2' I2 - GLU122:OE2 2.91 I O 
S1' 
H16 GLY197:O 2.67 H O 
H17 - MET196:O 2.72 H O 
 
S1 
Te - GLY73:HA2 2.95 Te H 
Te - GLY27:O 3.06 Te O 
I2 - GLY27:HA1 3.20 I H 
I3 - GLY27:HA2 2.93 I H 
I2 - GLY73: HA2 3.27 I H 
Te - CYS29:SG 2.91 Te SG 
I2 - ASN72:O 2.99 I O 
H3 - GLY74:O 2.28 H O 
H4 - GLY74:N 2.84 H N 
 
S2 
H1 - GLY198:O 2.21 H O 
H9 - GLY198:O 2.72 H O 
H12 -  GLY198:O 2.68 H O 
1 1gmy is the PDB code of the Cat B structure used for the dock-
ing experiments. 
 
Fig. 8 shows a detailed view of the immediate coordina-
tion environment about the tellurium atom bound to the 
active site of Cat B.  It is remarkable the disposition of the 
donor atoms matches very closely those found in the crystal 
structure of 1, Fig 8 insert. 
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Fig. 8.  Detail of the coordination geometry about the tellurium 
atom in the docked ligand complex, and its comparison with the 
immediate geometry found in the crystal structure of 1. 
 
Finally, Fig. 9 shows the superimposition of the interacting 
alkyl-derivative 1ꞌ and benzyl-derivative 3ꞌ, i.e. 3 less one 
chloride, in the active site of Cat B.  In accord with 
Schechter and Berger’s nomenclature [48], the active site of 
all proteases comprises several sub-sites.  The sub-sites on 
the N-terminus are named S1, S2, S3…Sn, while those on 
the C-terminus are labelled S1ꞌ, S2ꞌ, S3ꞌ…Snꞌ.  Previous 
work revealed that the inhibitory activity is dependent on 
the binding modes of the ligands and simultaneous binding 
to the S1ꞌ and S2ꞌ sub-sites results in significant inhibitory 
activity.  In the present work, the close superimposition of 
the two ligands, 1ꞌ and 3ꞌ, suggests that as far as interacting 
with the active site is concerned, the alkyl organotellurium 
derivative is just as effective in binding as the benzyl deriv-
ative. 
 
 
Fig. 9.  View of the interaction of ligands 1ꞌ and 3ꞌ (purple) 
docked into the active site of Cat B, highlighting the similarity of 
the interactions and conformations of the “ligands”.  The sub-sites 
are coloured: S1 (blue), S2 (pink), S1ꞌ (green), 2ꞌ (violet) and 3ꞌ 
(orange). 
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Conclusions 
Biologically active organotellurium compounds 
often inhibit Cathepsin B.  Crystallography on an 
alkyl derivative, [CH3(CH2)2C(I)=C(H)](nBu)TeI2, 
1, reveals a C2I2 donor set but, allowing for the ste-
reochemically active lone pair of electrons, along 
with intra- and inter-molecular Te…I interactions, the 
coordination geometry is based on a Ψ-pentagonal 
bipyramid.  Computational docking of 1ꞌ, i.e. 1 less 
one iodide, in Cathepsin B indicates the formation of 
a Te–S(cys29) bond and a coordination environment 
analogous to that seen in the crystal structure of 1.  
Notably, the interaction of 1ꞌ is very similar to those 
exhibited by benzyl organotellurium species sug-
gesting biological screening of alkyl organotellurium 
compounds is likely to provide promising outcomes, 
especially when these derivatives are generally re-
garded as having low toxicity [49, 50]. 
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